tirzepatide maintenance plan Monthly GLP-1 for Weight Maintenance Dose Tirzepitide | TikTok
Description
Tirzepatide was the second dual incretin receptor agonist advanced to clinical study
Journal of Dental and Medical Sciences
In contrast, Ozempic (semaglutide) is a medically prescribed GLP-1 receptor agonist for type 2 diabetes and weight management
The working solution was freshly prepared before use
Design In the obesity trial, 338 participants (mean age 48 years, 48% women, mean BMI 37.3 kg/m 2 ) were randomised (2:1:1:1:1:2:2) to retatrutide 1 mg, 4 mg (titration), 4 mg (no titration), 8 mg (slow titration), 8 mg (fast titration), 12 mg or placebo over 48 weeks [45]
Are there side effects when using semaglutide for insulin resistance treatment
